I agree that this site is using cookies. You can find further informations here.
X
Yamaguchi, Shigeru
1326  results:
Search for persons X
?
1

Increased CD44 expression in primary meningioma: its clinic..:

Sawaya, Ryosuke ; Yamaguchi, Shigeru ; Ishi, Yukitomo...
Journal of Neurosurgery.  , 2024
Link: https://doi.org/10.3171/..
 
?
2

Identifying G6PC3 as a Potential Key Molecule in Hypoxic Gl..:

Okamoto, Michinari ; Yamaguchi, Shigeru ; Sawaya, Ryosuke...
BioMed Research International.  2024 (2024)  - p. 1-10 , 2024
Link: https://doi.org/10.1155/..
 
?
3

Clinical outcomes for olfactory neuroblastoma:

Nakazono, Akira ; Motegi, Hiroaki ; Suzuki, Masanobu...
Frontiers in Oncology.  14 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
4

Molecular Field Analysis in Half-Titanocene Complexes: Comp..:

Yamaguchi, Shigeru ; Kikuchi, Takahiro ; Tanaka, Kenichi.
Catalysis Science & Technology.  , 2024
Link: https://doi.org/10.1039/..
 
?
5

Pre- and post-operative semicircular canal function evaluat..:

Fujiwara, Keishi ; Morita, Shinya ; Motegi, Hiroaki...
Auris Nasus Larynx.  51 (2024)  3 - p. 542-547 , 2024
Link: https://doi.org/10.1016/..
 
?
6

10007-ACT-2 FIRST IN HUMAN STUDY OF DSP-0390, AN ORAL EMOPA..:

Arakawa, Yoshiki ; Goldlust, Samuel A ; Colman, Howard...
Neuro-Oncology Advances.  5 (2023)  Supplement_5 - p. v2-v2 , 2023
Link: https://doi.org/10.1093/..
 
?
7

CTNI-67. FIRST IN HUMAN STUDY OF DSP-0390, AN ORAL EMOPAMIL..:

Arakawa, Yoshiki ; Goldlust, Samuel ; Colman, Howard...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v92-v92 , 2023
Link: https://doi.org/10.1093/..
 
?
8

Supratentorial multifocal gliomas associated with Ollier di..:

Ikeda, Hiroshi ; Yamaguchi, Shigeru ; Ishi, Yukitomo...
Neuropathology.  43 (2023)  5 - p. 413-420 , 2023
Link: https://doi.org/10.1111/..
 
?
9

RARE-03. GENOME-WIDE ASSOCIATION STUDY OF INTRACRANIAL GERM..:

Terashima, Keita ; Sonehara, Kyuto ; Kimura, Yui...
Neuro-Oncology.  25 (2023)  Supplement_1 - p. i33-i34 , 2023
Link: https://doi.org/10.1093/..
 
?
10

CTNI-72. PHASE II TRIAL OF PATHOLOGY-BASED THREE-GROUP TREA..:

Fulvio D'Angelo, Hirokazu Takami ; Suzuki, Tomonari ; Takabatake, Kazuhiko...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v94-v94 , 2023
Link: https://doi.org/10.1093/..
 
?
11

Slow-growing WNT medulloblastoma with atypical magnetic res..:

Mizushima, Makoto ; Okamoto, Michinari ; Yamaguchi, Shigeru...
Journal of Neurosurgery: Case Lessons.  6 (2023)  7 - p. , 2023
Link: https://doi.org/10.3171/..
 
?
12

Safety and efficacy of tumour-treating fields (TTFields) th..:

Nishikawa, Ryo ; Yamasaki, Fumiyuki ; Arakawa, Yoshiki...
Japanese Journal of Clinical Oncology.  53 (2023)  5 - p. 371-377 , 2023
Link: https://doi.org/10.1093/..
 
?
13

The need of radiotherapy optimization for glioblastomas con..:

Nishioka, Kentaro ; Takahashi, Shuhei ; Mori, Takashi...
Japanese Journal of Radiology.  41 (2023)  10 - p. 1062-1071 , 2023
Link: https://doi.org/10.1007/..
 
?
14

A common deletion at BAK1 reduces enhancer activity and con..:

Sonehara, Kyuto ; Kimura, Yui ; Nakano, Yoshiko...
Nature Communications.  13 (2022)  1 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
15

PEDT-10 PHASE II TRIAL OF PATHOLOGY-BASED THREE-GROUP TREAT..:

Takami, Hirokazu ; Suzuki, Tomonari ; Takabatake, Kazuhiko...
Neuro-Oncology Advances.  4 (2022)  Supplement_3 - p. iii11-iii11 , 2022
Link: https://doi.org/10.1093/..
 
1-15